Search results
P!NK Sues Pharrell Over Attempt to Trademark Term “P.Inc”
Consequence of Sound via Yahoo News· 6 days agoP!NK argues that the trademark is "likely to cause confusion, mistake and/or deception" among...
Invincible North Korea: Did Animation Get Outsourced to NK?
COMINGSOON.net via Yahoo News· 19 hours agoHow does this happen? The post Invincible North Korea: Did Animation Get Outsourced to NK? appeared...
Br!NK! NEW PLAY FESTIVAL Returns for Its Tenth Year In May
Broadway World· 2 days agoRenaissance Theaterworks presents the tenth annual Br!NK! Since 2013, RTW has invited Midwestern women playwrights to submit their work for consideration in the Br!
Megan Thee Stallion: Uwari umufotozi we aramushinja gusambanira iruhande rwe
BBC News· 17 hours agoAbahagarariye Megan Thee Stallion bavuga ko ibyo birego bigamije gusa kumusebya
How immune cells communicate to fight viruses: New mouse model enables identification of chemokine...
Medical Xpress· 7 hours agoResearchers at the University Hospital Bonn (UKB) and the University of Bonn have developed a new...
Benny Blanco to Receive BMI President’s Award at 2024 BMI Pop Awards
Billboard via Yahoo News· 6 hours agoPrevious recipients of the award include Luis Fonsi, Noel Gallagher, Ellie Goulding, Imagine...
From P!nk to The Rolling Stones, here are the biggest summer concerts in MA, RI in 2024
Worcester Telegram & Gazette via Yahoo News· 3 days agonk August 23, 25, 25: Kenny Chesney 2024 concerts TD Garden, Boston The home of the Bruins and the...
Pharrell Sued Again - This Time P!nk Is Battling Over P.Inc Trademark
AllHipHop.com· 4 days agoSinger P!nk is suing Pharrell Williams over his attempt to trademark the word P.Inc, claiming its too close to her own name!
Pink takes legal action against Pharrell Williams over his 'P.Inc' trademark
Business Insider via Yahoo News· 5 days agoPink and Pharrell Williams.Serge BENHAMOU/Getty Images Lawyers for Pink, often stylized P!nk, filed...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 1 day agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows a preliminary 26.9% response rate, the primary endpoint of the studyData